Login / Signup

3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.

Francesco PorpigliaCristian FioriRiccardo BertoloAndrea GiordanoEnrico CheccucciDiletta GarrouGiovanni CattaneoStefano De LucaDaniele Amparore
Published in: BJU international (2018)
The extended follow-up period corroborated our previous findings and suggests that TIND implantation is safe, effective and well-tolerated, for at least 36 months after treatment.
Keyphrases
  • prostate cancer
  • benign prostatic hyperplasia
  • combination therapy